Grouping strains by chemotyping may prove useful in ascertaining how strains are related, and the kind of medical benefits you can expect to see with strains from a given chemotype class.
The process, which was developed and tested in the Netherlands under strict regulatory guidelines, involves the growing of selected cannabis plants at a cGMP facility followed by extraction of the cannabinoid molecules from cannabis flowers.
An early lab pilot of molecular tagging technology has demonstrated how members of the cannabis supply chain could be able to prove, with scientific certainty, that their products originate from their facilities or other legal sources.
Acreage plans to use supercritical CO2 extraction technology to produce safe, non-toxic, carbon-neutral, customizable, premium quality cannabis oils.
The rapid global adoption of legal cannabis legislation has accelerated the need to secure and truly validate cannabis supply chains from seed-to-sale.
Abattis Bioceuticals has announced the successful completion of experiments utilizing column chromatography for cannabinoid extraction.
The partnership will utilize Steep Hill's expertise in analytical testing to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis.
Analyzing the complex chemistry of the cannabis plant may help scientists to develop specific cannabis-based drugs for specific conditions.